Eishin Oki

472 total citations
21 papers, 320 citations indexed

About

Eishin Oki is a scholar working on Nephrology, Rheumatology and Genetics. According to data from OpenAlex, Eishin Oki has authored 21 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 13 papers in Rheumatology and 6 papers in Genetics. Recurrent topics in Eishin Oki's work include Renal Diseases and Glomerulopathies (14 papers), Systemic Lupus Erythematosus Research (13 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Eishin Oki is often cited by papers focused on Renal Diseases and Glomerulopathies (14 papers), Systemic Lupus Erythematosus Research (13 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Eishin Oki collaborates with scholars based in Japan and Germany. Eishin Oki's co-authors include Hiroshi Tanaka, Etsuro Ito, Kazushi Tsuruga, Tomomi Aizawa‐Yashiro, Koji Tsugawa, Koichi Suzuki, Tadaatsu Imaizumi, Shojiro Watanabe, Hideo Yoshida and Tomoh Matsumiya and has published in prestigious journals such as Nephrology Dialysis Transplantation, Acta Paediatrica and Pediatric Nephrology.

In The Last Decade

Eishin Oki

20 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eishin Oki Japan 12 162 142 114 59 47 21 320
Juan Javier Lichauco Philippines 8 284 1.8× 71 0.5× 171 1.5× 29 0.5× 22 0.5× 12 397
María del Mar Ayala Gutiérrez Spain 7 210 1.3× 92 0.6× 95 0.8× 22 0.4× 50 1.1× 12 283
Matthias Schneider Germany 6 402 2.5× 130 0.9× 164 1.4× 27 0.5× 50 1.1× 11 462
Michela Ferro Italy 10 109 0.7× 158 1.1× 46 0.4× 44 0.7× 9 0.2× 31 316
L M Vilá Puerto Rico 5 439 2.7× 33 0.2× 188 1.6× 23 0.4× 22 0.5× 7 507
Zhengzhao Liu China 7 219 1.4× 197 1.4× 109 1.0× 19 0.3× 50 1.1× 13 300
Woon Leung Ng China 8 532 3.3× 299 2.1× 193 1.7× 16 0.3× 161 3.4× 9 569
Ashira Blazer United States 11 154 1.0× 34 0.2× 115 1.0× 37 0.6× 11 0.2× 24 282
Farah Tamirou Belgium 12 522 3.2× 319 2.2× 196 1.7× 25 0.4× 174 3.7× 22 615
MJ Cuadrado United Kingdom 6 278 1.7× 62 0.4× 139 1.2× 5 0.1× 33 0.7× 8 336

Countries citing papers authored by Eishin Oki

Since Specialization
Citations

This map shows the geographic impact of Eishin Oki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eishin Oki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eishin Oki more than expected).

Fields of papers citing papers by Eishin Oki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eishin Oki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eishin Oki. The network helps show where Eishin Oki may publish in the future.

Co-authorship network of co-authors of Eishin Oki

This figure shows the co-authorship network connecting the top 25 collaborators of Eishin Oki. A scholar is included among the top collaborators of Eishin Oki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eishin Oki. Eishin Oki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Hiroshi, et al.. (2014). Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis. Lupus. 23(8). 813–818. 16 indexed citations
2.
Tanaka, Hiroshi, Shojiro Watanabe, Tomomi Aizawa‐Yashiro, et al.. (2013). Long-Term Tacrolimus-Based Immunosuppressive Treatment for Young Patients with Lupus Nephritis: A Prospective Study in Daily Clinical Practice. Nephron Clinical Practice. 121(3-4). c165–c173. 33 indexed citations
3.
Aizawa‐Yashiro, Tomomi, Kazushi Tsuruga, Shojiro Watanabe, et al.. (2011). Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome. Pediatric Nephrology. 26(8). 1255–1261. 18 indexed citations
4.
Tsuruga, Kazushi, Shojiro Watanabe, Eishin Oki, et al.. (2011). Imbalance towards Th1 pathway predominance in purpura nephritis with proteinuria. Pediatric Nephrology. 26(12). 2253–2258. 11 indexed citations
5.
6.
Imaizumi, Tadaatsu, Hiroshi Tanaka, Tomoh Matsumiya, et al.. (2010). Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells. Nephrology Dialysis Transplantation. 25(11). 3534–3539. 46 indexed citations
7.
Tsuruga, Kazushi, Eishin Oki, Tomomi Aizawa‐Yashiro, et al.. (2010). Potential Th1/Th2 predominance in children with newly diagnosed IgA nephropathy. Acta Paediatrica. 99(10). 1584–1586. 11 indexed citations
8.
Tanaka, Hiroshi, Eishin Oki, Kazushi Tsuruga, et al.. (2010). Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis. Clinical Rheumatology. 29(9). 1049–1054. 18 indexed citations
9.
Suzuki, Koichi, Eishin Oki, Kazushi Tsuruga, et al.. (2010). Benefits of Once-Daily Administration of Cyclosporine A for Children with Steroid-Dependent, Relapsing Nephrotic Syndrome. The Tohoku Journal of Experimental Medicine. 220(3). 183–186. 6 indexed citations
10.
Imaizumi, Tadaatsu, Hiroshi Tanaka, Atsushi Tajima, et al.. (2010). Retinoic acid-inducible gene-I (RIG-I) is induced by IFN-γ in human mesangial cells in culture: possible involvement of RIG-I in the inflammation in lupus nephritis. Lupus. 19(7). 830–836. 24 indexed citations
11.
Suzuki, Koichi, Koji Tsugawa, Eishin Oki, et al.. (2009). Dense deposit disease presenting as endocapillary proliferative nephritis. Pediatrics International. 51(5). 739–741.
12.
Tsuruga, Kazushi, et al.. (2009). [Early initiation of peritoneal dialysis for the treatment of a patient with refractory nephrotic syndrome].. PubMed. 51(1). 68–73. 1 indexed citations
13.
Suzuki, Koichi, Koji Tsugawa, Eishin Oki, et al.. (2008). Vesical varices and telangiectasias in a patient with ataxia telangiectasia. Pediatric Nephrology. 23(6). 1005–1008. 17 indexed citations
14.
Tanaka, Hiroshi, Eishin Oki, Kazushi Tsuruga, et al.. (2008). Mizoribine Treatment of Young Patients with Severe Lupus Nephritis: A Clinicopathologic Study by the Tohoku Pediatric Study Group. Nephron Clinical Practice. 110(2). c73–c79. 22 indexed citations
15.
Oki, Eishin, Koji Tsugawa, Koichi Suzuki, Etsuro Ito, & Hiroshi Tanaka. (2008). Leukocytapheresis for the treatment of refractory Henoch–Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy. Rheumatology International. 28(11). 1181–1182. 8 indexed citations
16.
Tsugawa, Koji, Eishin Oki, Koichi Suzuki, et al.. (2007). Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis. Pediatric Nephrology. 23(3). 395–401. 17 indexed citations
17.
18.
Tanaka, Hiroshi, Koji Tsugawa, Eishin Oki, Koichi Suzuki, & Etsuro Ito. (2007). Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients. Clinical Rheumatology. 27(1). 85–89. 19 indexed citations
19.
20.
Tanaka, Hiroshi, Koji Tsugawa, Koichi Suzuki, et al.. (2006). Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus. European Journal of Pediatrics. 166(10). 1053–1055. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Javier Lichauco Breakdown of academic impact, for papers by María del Mar Ayala Gutiérrez Breakdown of academic impact, for papers by Matthias Schneider Breakdown of academic impact, for papers by Michela Ferro Breakdown of academic impact, for papers by L M Vilá Breakdown of academic impact, for papers by Zhengzhao Liu Breakdown of academic impact, for papers by Woon Leung Ng Breakdown of academic impact, for papers by Ashira Blazer Breakdown of academic impact, for papers by Farah Tamirou Breakdown of academic impact, for papers by MJ Cuadrado
Rankless by CCL
2026